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Abstract 
Ten of the proteinogenic amino acids can be generated abiotically while the remaining thirteen 
require biology for their synthesis. Paradoxically, the biosynthesis pathways observed in nature 
require enzymes that are made with the amino acids they produce. For example, Escherichia coli 
produces cysteine from serine via two enzymes that contain cysteine. Here, we substituted 
alternate amino acids for cysteine and also methionine, which is biosynthesized from cysteine, in 
serine acetyl transferase (CysE) and O-acetylserine sulfhydrylase (CysM).  CysE function was 
rescued by cysteine-and-methionine-free enzymes and CysM function was rescued by cysteine-
free enzymes. Structural modeling suggests that methionine stabilizes CysM and is present in the 
active site of CysM. Cysteine is not conserved among CysE and CysM protein orthologs, 
suggesting that cysteine is not functionally important for its own synthesis. Engineering 
biosynthetic enzymes that lack the amino acids being synthesized provides insights into the 
evolution of amino acid biosynthesis and pathways for bioengineering. 
 How life emerged from an inorganic prebiotic world to become the complex biological systems 
of today remains a pressing yet unsolved question. One problem within this grand puzzle is how 
the building blocks for polypeptides, which are the primary catalysts and structural elements for 
life, originated. Ten of the twenty standard proteinogenic amino acids—glycine, alanine, aspartic 
acid, glutamic acid, valine, serine, ileucine, leucine, proline, and threonine—are found in 
multiple abiotic settings and thus are likely to have been present on prebiotic Earth1, 2. Some of 
these amino acids were transported to Earth via meteorites and comets, while others were 
generated via terrestrial geochemical events such as lightening, volcanism, and hydrothermal 
syntheses3.  
 While it has been hypothesized that short RNA fragments formed ribozymes to catalyze 
various chemical reactions4, there is no conclusive evidence for ribozymes involved in proto-
metabolism where they would have synthesized the entire library of the modern amino acids, nor 
even if such syntheses pre- or post-dated the origin of RNA. The set of 20 amino acids is realized 
via chemical reactions encoded by protein enzymes, and in most cases these enzyme contain the 
amino acids they synthesize. However, it seems likely that in an earlier time polypeptides 
composed of a limited abiotically-derived set of amino acids might have served as biosynthetic 
enzymes. Such polypeptides could have played a role in developing and diversifying amino acid 
biosynthesis pathways.  
 Thus, we hypothesized that we could create biosynthetic enzymes that did not contain the 
amino acid they synthesized. Our aim was to construct enzymes that lack the amino acids they 
synthesize to demonstrate that it was possible to solve the “chicken-and-egg” puzzles found in 
modern amino acid biosynthesis. We focused on the biosynthesis of cysteine – an amino acid 
that plays an important role in modern protein structure and function. For example, two cysteine 
residues can form a disulfide bridge, a structure that results from the thiol group of cysteine and 
is unique among the twenty proteinogenic amino acids. Disulfide bridges are able to cross-link 
two cysteines in the same peptide, allowing for secondary structure, or join separate polypeptide 
chains forming tertiary structures5. Cysteine is also used to coordinate iron-sulfur cluster 
prosthetic groups that are found in key biochemical functions such as electron transfer, catalytic 
center and oxygen sensing6. In addition, cysteine is the key substrate providing the sulfur during 
the biosynthesis of methionine.  However, cysteine is not thought to arise via prebiotic synthesis 
nor is cysteine found in abiotic sources such as meteorites or cometary ice. 
 In plants and various bacterial and archaeal species, cysteine is synthesized via a two-step 
pathway from its precursor serine, which is derived from 3-phosphoglyceric acid in the 
glycolysis pathway (Figure 1). Although in some heterotrophic species of bacteria and 
eukaryotes cysteine is produced via the metabolism of methionine, methionine originally evolved 
from cysteine in autotrophs7. While the exact archaeal pathway remains unknown, genes similar 
to E. coli cysE, cysK, and cysM has been found in archaea8. In E. coli serine acetyltransferase 
(CysE) converts serine into O-acetylserine and then cysteine synthase A and B (CysK and 
CysM) incorporate sulfur from either hydrogen sulfide or thiosulfate to form cysteine. So far 
several attempts have been made to create functional proteins with simplified alphabets, such as 
a orotate phosphoribosyltransferase lacking seven amino acid (C, H, I, M, N, Q, and W)9 and in 
an extreme case a functional chorismate mutase using only nine amino acids10. We took a similar 
approach to design, synthesize, and validate the functionality of cysteine- and methionine-less 
cysE, and cysM genes using cysteine-dependent auxotrophic E.coli strains.  
 
Results 
Synthetic reconstruction of sulfur-free proteins involved in the cysteine synthesis pathway 
 To solve the “chicken-and-egg” biosynthetic puzzle for cysteine we designed a total of 
four modified synthetic genes cysE-C, cysE-CM, cysM-C and cysM-CM, corresponding to either 
cysteine-deficient (C) or cysteine-methionine (CM) deficient versions of E.coli cysE and cysM 
genes (Figure 2).  Three and two cysteine residues in wild-type E.coli cysE and cysM genes were 
changed to serine, respectively. Serine was chosen due to its role as a precursor of cysteine 
(Figure 1) as well as its structural resemblance. Additionally, eight and eleven methionine 
residues were changed to leucine/isoleucine, starting from cysteine-deficient cysE-C and cysM-
C. The methionine to leucine/isoleucine substitution is thought to be a ‘safe’ substitution that 
does not disturb protein structure and results in a similar hydrophobicity to methionine11. 
Synthesized gene sequences were first PCR amplified using tagged primer sequences containing 
HindIII and XhoI cut sites (Supplementary Figure 1). Each gene was then cloned into the pUC19 
expression vector. Cloned gene sequences were further confirmed based on Sanger sequencing. 
 
Structural analysis of CysE and CysM proteins 
 To explore the potential effects of these amino acid substitutions in the context of protein 
structure, we analyzed the crystal structures of the native CysE and CysM proteins. The 
quaternary structure of CysE (PDB: 1T3D) is a dimer of trimers, with each of the trimer subunits 
creating three separate active sites (Figure 3A). No cysteine-cysteine disulfide bridges are 
expected because the closest cysteine residues, C3 and C83, have a separation of 13.2 Å which is 
significantly greater than the accepted bridge length of 2.3 Å12. In addition, several methionine-
aromatic ring motif interactions, with a separation of ~5 Å, were observed that may stabilize 
protein structure13; one of such was between the M58 residue and the F131 residue (Figure 3A).  
 The quaternary structure of CysM (PDB: 2BHS) consists of two monomers that come 
together to form a dimer with two actives sites (Figure 3B). Like CysE, CysM does not have any 
predicted cysteine-cysteine disulfide bridges. The closest two cysteine residues, C252 and C280, 
have a separation of 8.6 Å, which is greater than the 2.3 Å typical bridge length. CysM also has 
several methionine-aromatic ring motifs (e.g., M173 and F221) (Figure 3B). 
 By performing a search of related sequences and protein structures using HHblits we 
obtained multiple sequence alignments (MSA) for CysE and CysM. For CysE, a MSA with 
1,918 sequences was obtained. This MSA had a probability of 100.0, E-value of 3 x 10-146, P-
value of 3 x 10-151, score of 828.2, 0.0 SS, 273 Cols, 1-273 Query HMM, and 42-314 (314) 
template HMM. For CysE, a MSA with 124 sequences was obtained with a probability of 100.0, 
1 x 10-160 E-value, 9 x 10-166 P-value, 907.8 score, 0.0 SS, 302 Cols, 1-303 Query HMM, and 4-
315 (315) template HMM. The consensus amino acid for each residue in CysE and CysM was 
determined and displayed by HHblits (Supplementary Figure 2).  
Auxotrophy of cysteine-dependent E. coli knockout strains 
 To determine if the cysteine biosynthesis enzymes lacking cysteine and methionine can 
enable biosynthesis of cysteine we obtained the K-12 E. coli single knockout strain ΔcysE from 
the Keio collection14. We then constructed a double knockout strain, ΔcysKΔcysM, by deleting 
the two homologous cysteine synthetase A and B genes, which are responsible for converting O-
acetylserine to L-cysteine. We tested the auxotrophy of ΔcysE and ΔcysKΔcysM knockout strains 
by observing growth on LB medium, M9-glucose medium and M9-glucose medium 
supplemented with 0.5 mM L-cysteine. E. coli colonies were observed on LB and M9-glucose 
medium containing cysteine after 24 and 48 h respectively, while no growth was observed on 
M9-glucose minimal medium after 72 h. indicating that the knockouts strains are cysteine-
dependent auxotrophs (Figure 4). 
Cysteine-free proteins rescue cysteine-dependent knockout strains 
Rescue experiments were conducted by transforming three cysE variants (cysE, cysE-C 
and cysE-CM) into the ΔcysE strain and three cysM variants (cysM-opt, cysM-C and cysM-CM) 
into the ΔcysKΔcysM strain. Wild-type cysE and codon optimized cysM-opt served as positive 
controls, whereas pUC19 vector with lacZ gene was used as a negative control. Transformants 
were plated on M9 glucose with ampicillin, kanamycin and IPTG supplemented and incubated at 
30 ℃. Colonies were observed on plates with the native cysE and cysM transformed cells and the 
synthetic cysE-C, cysE-CM and cysM-C transformed cells. These results suggest the recovery of 
cysE and cysM function using cysteine deficient enzymes. However, no growth was observed for 
plates with cysM-CM transformed cells. Negative controls, with lacZ transformed cells, also 
showed no growth (Figure 5). Initial transformation efficiencies for fully synthesized gene 
variants were low, possibly due to the errors during gene assembly or PCR amplification. 
Therefore, to confirm that the cysteine-dependent auxotrophs were rescued by the transformed 
synthetic genes, we isolated single colonies of cysE-C, cysE-CM and cysM-C from M9-glucose 
plates and expanded the colonies in liquid LB +Amp culture overnight at 37oC. The plasmids 
from these cells were then extracted for sequencing. Sequencing results indicated that all three 
genes recovered from rescued cells encoded the specific sequences as designed with no reverse 
mutations.. Likewise, we isolated cysM-CM transformed colonies from the LB +Amp plate 
(since no cells grew on M9-glucose) and confirmed that the plasmid insert sequence was exactly 
the as-designed cysM-CM sequence. The isolated plasmids were further re-transformed into new 
ΔcysE and ΔcysKΔcysM knockout cells and plated on M9-glucose +Amp +Kan +IPTG at 30°C 
along with the positive and negative controls. Colonies were again observed after 72 h indicating 
that the observed rescue phenotype is specific to the synthetic genes encoded by the plasmids 
(Figure 5).  
 
Growth curve analysis reveals shorter lag phase in cysteine-free gene transformants  
 To test whether the synthetic genes functioned better, worse, or the same as the modern 
genes that they had replaced, we performed comparative growth curve assays in liquid LB and 
M9 glucose media for four ΔcysE transformants, cysE, cysE-C, cysE-CM, and empty-pUC19 
(Figure 6A and 6B), and four ΔcysKΔcysM transformants, cysM-opt, cysM-C, cysM-CM, and 
empty pUC19 (Figure 6C and 6D), in a 96-well plate for 48 h to observe how each synthetic 
gene affects distinct phases (lag, exponential, and stationary) during continuous culture. Cells 
were pre-cultured in LB +Amp and washed three times with 0.9% saline solution to remove all 
nutrients before inoculation to LB or M9 glucose medium +Amp + Kan supplemented with 
IPTG for gene expression. As predicted, all the transformants grew identically without a 
noticeable lag phase in the LB +IPTG condition. However, when grown in M9 glucose medium, 
auxotrophic strains were rescued by cysteine-free CysE-C and CysM-C have shown significantly 
shorter lag phase compared to native E. coli enzymes (Figure 6B and 6D).  
 
Discussion 
The focus of this study was to address the “chicken-and-egg” dilemma of cysteine 
biosynthesis by introducing synthetic cysteine-free and cysteine+methionine-free enzymes into 
modern E. coli deficient in these enzymes. The underlying hypothesis is that primordial 
polypeptides made from the abiotic subset of modern proteinogenic amino acids can serve as 
ancestral metabolic catalysts that, over evolutionary time scales, diversify and increase the 
repertoire of amino acids found today. Because no conclusive evidence for prebiotic cysteine and 
methionine has been reported, the most parsimonious explanation is that cysteine was created 
during the evolution of the metabolic network from its amino acid precursor serine, presumed to 
be a common proteinogenic amino acids in prebiotic settings3. Our rescue experiments using 
CysE-C and CysM-C enzymes imply that the acetylation of L-serine and the conversion of ester 
into cysteine can occur in a cysteine-independent manner. Interestingly, growth curve 
experiments revealed a shorter lag phase of auxotrophs rescued by cysteine-free enzymes CysE-
C and CysM-C compared to their wild-type analogs (Figure 6). Lag phase is a period which cells 
adjust their metabolic activity to the new environment and synthesize enzymes and factors 
necessary for cell division15. Since cysteine is no longer a limiting factor for CysE-C and CysM-
C protein synthesis, rescued cells can carry out cysteine production immediately under cysteine-
deprived condition. Thus, simplification of amino acid alphabets for the enzymes directly 
involved in the amino acid biosynthesis pathway may well be advantageous especially under 
conditions where a specific amino acid is absent. 
 We pursued reconstructing the same cysteine biosynthesis pathway using synthetic CysE 
and CysM enzymes lacking not only cysteine but methionine as well to extend our hypothesis 
that cysteine production can be carried out by not only cysteine-free enzymes but by entirely 
sulfur-free enzymes. Therefore, in addition to the previous cysteine substitution, we replaced all 
methionine residues with either leucine or isoleucine (Met to Leu/Ile), except the initiator N-
Formylmethionine (fMet) (Figure 2). Accordingly, the CysE-CM protein, which consist of only 
18 types of amino acids, has successfully complemented the loss of CysE function, whereas the 
CysE-CM protein failed to rescue the loss of CysE. Typically, methionine does not carry any 
catalytic activity due to its unbranched, hydrophobic side chain which contains a thioester; 
however, S/π interactions between the sulfur atom and aromatic amino acids have recently been 
reported to increase the stability of a protein structure by 1-1.5 kcal/mol13. According to the 
CysM protein structure, two methionine-aromatic motifs were observed near the active center of 
the protein which could contribute to stabilizing the coils (173-176) and (217-222) as well as the 
α helix (177-187) and the β sheet (168-172) which are in close proximity and keeping the active 
center intact (Figure 3B). Furthermore, two other methionine residues, M95 and M116, are part 
of the active center known to interact with sulfate ions10. Therefore, replacement of these key 
methionine residues from CysM could have resulted in losing the ability to recognize and 
incorporation sulfate as well as inducing a structural alteration around the active site leading to 
loss of catalytic function or substrate recognition. In contrast, CysE does not have any cysteine 
or methionine residues within or near the active site; thus, the amino acid substitutions of 
cysteine and methionine should have less of an effect on the enzymatic function.  
The ability to function without cysteine and methionine in CysE and without cysteine in 
CysM raises the question of the importance of these residues for enzymatic function in these 
enzymes. The consensus sequences of structurally aligned CysE orthologs and CysM orthologs, 
show that cysteine residues are not conserved at all, whereas some methionine residues are 
strictly conserved among the orthologous proteins (Supplementary Figure 2). Therefore we 
assume that during the evolution of the CysE and CysM cysteine was incorporated into the 
enzymes through random drift rather than providing benefits to their structural stability or 
function. However, at least two methionine residues, M95 and M119, are involved in the active 
center of CysM (Figure 3B) to maintain the structural integrity of active site and to interact with 
sulfur containing H2S and thiosulfate16. The strict conservation among orthologous proteins 
suggests the involvement of methionine residues from early stage of CysM evolution 
(Supplementary Figure 2). 
While it is becoming more feasible to create proteins with reduced alphabets17, there are 
no reports of proteins with a limited alphabet being directly involved in the biosynthesis of new 
amino acids. Thus, we believe this work to be the first example of enzymes that lack the amino 
acid they produce synthesizing that amino acid . While it is extremely unlikely that primordial 
cysteine synthesis enzymes were similar to the ones that we see now, the rational engineering of 
proteins via synthetic biology approaches have provided an instance for how biological pathways 
could have arisen from proteins utilizing a reduced set of amino acids. Similar studies should be 
explored for other amino acid biosynthesis pathways. 
 
Materials and Methods 
Gene design for cysteine deficient cysE and cysM genes  
 E. coli K-12 substrain MG1655 cysE (Genbank ID: 732686788) and cysM (Genbank ID: 
732683705) genes were selected to create synthetic protein products without any cysteine. Gene 
sequences were modified using the software Geneious 8.0. Codons corresponding to CysE and 
CysM cysteine residues were substituted with serine codons in the gene sequence. To create the 
cysE-C gene,  A total of three cysteine residues—located at amino acid residues 3, 23, and 83—
were thus replaced with serine to create the cysE-C gene. Likewise, a total of two cysteine 
residues—located at amino acid residues 252 and 280— were replaced with serine for cysM-C. 
We codon-optimized the cysM-C gene using the online codon optimization service provided by 
Integrated DNA Technologies (Coralville, IA USA) to achieve efficient expression in E. coli. 
Design for cysteine-methionine deficient cysE and cysM genes  
 Enzymes lacking cysteine and methionine were created based on the cysE-C and cysM-C 
gene sequences. The codons for methionine residues were changed to those for either leucine or 
isoleucine. The cysE-CM gene was created by replacing the methionine codons by the leucine 
codon in all eight residues (26, 48, 58, 77, 155, 201, 254 and 256) of the cysE-C gene construct. 
Similarly, the cysM-CM gene was created by replacing the eight methionine codons of the cysM-
C gene (residues 19, 48, 78, 103, 119, 173, 186, and 241) with leucine and three methionine 
codons with those for isoleucine (87, 95, and 129). CysM-CM was also codon-optimized using 
the online codon optimization service provided by Integrated DNA Technologies for efficient 
expression in E. coli. 
Visualizing the structures of CysE and CysM proteins 
 Serine acetyltransferase (EC 2.3.1.30; CysE), a 273 amino acid protein, is arranged as a 
dimer of loosely stacked trimers to carry out serine O-acetyltransferase function18. The cysteine 
synthase O-acetylserine sulfhydrylase ((EC 2.5.1.47; CysM), is a 303 amino acid protein exists 
as a dimer and is one of the two isozymes that catalyzes the second step of cysteine synthesis16. 
The crystal structures of CysE (PDB ID: 1T3D) and CysM (PDB ID: 2BHS) were obtained from 
the RSCB Protein Data Bank. PDB files were imported into PyMOL version 1.6.0.0 
(Schrodinger, New York, NY). The residues involved with creating the active center pocket 
(catalytic core and substrate recognition) were identified. The active center residues are 92, 143, 
157-158, 178, 184-185,192, 204, 222, and 235 for CysE19 and 41, 68-72, 95, 119, 140, 141, 174, 
175, 208-210, and 212 for CysM16. In addition to modeling, we performed a homology search by 
iterative HMM-HMM comparison using HHblits Release-2.18.2 (Tübingen, Germany) on the 
native E. coli CysE and CysM amino acid sequences. The multiple sequence alignment was 
performed with the following settings: FASTA alignment format, fraction of gaps <50%, 
uniprot20_Mar12 HMM database, 1 max iteration, global alignment mode, realign with MAC 
checked, and 0.0 MAC realignment threshold.  
Gene synthesis, cloning, and transformation 
 Five different gene constructs were synthesized using the gBlocks Gene Fragments 
technology (Integrated DNA Technologies, Coralville, IA USA). The gene constructs are cysE-C 
(cysE with cysteine replaced), cysE-CM (cysE with cysteine and methionine replaced), cysM-opt 
(codon optimized cysM gene using the online codon optimization platform provided by IDT), 
cysM-C (codon optimized cysM with cysteine replaced), and cysM-CM (codon optimized cysM 
with cysteine and methionine replaced). For each gene construct, we added sequences containing 
HindIII and XhoI restriction sites at the 5’ and 3’ ends. PCR amplification of the gene construct 
was carried out with Q5 High-Fidelity Master Mix (New England Biolabs Inc., Ipswich, MA, 
USA) using the forward tag primer (5’- GCTTGCATCGTACGTATCGG-3’), and the reverse 
tag primer (5’- AGACGTAACGACCAACGCTAG-3’). Amplification was performed in a T100 
Thermo Cycler (Bio-Rad Laboratories, Inc., Hercules, CA, USA) using a 30 s initial denaturation 
at 98 ℃, 30 cycles of 10 s denaturation at 98 ℃, 15 s annealing at 60 ℃, and 30 s extension at 72 
℃, and a final 2 min extension at 72 °C. PCR products were column purified using the GenCatch 
PCR Cleanup Kit (Epoch Life Science., Sugar Land, TX, USA) and verified using gel 
electrophoresis in a 1% (w/v) agarose gel in 1x TAE buffer run at 100V for 30 min. The 
resulting gel was stained with GelRed (Thermo Fisher Scientific Inc., Waltham, MA, USA).  
 For cloning and transformation, both the PCR products and the pUC19 vector (New 
England Biolabs) were digested using HindIII-HF and XhoI restriction enzymes at 37 ℃ for 1 h 
in 1x CutSmart buffer (New England Biolabs). The digested products were then cleansed of 
extraneous DNA using the MinElute Reaction Cleanup Kit (QIAGEN, Germantown, MD). Fifty 
nanograms of pUC19 and 50 ng of digested PCR products encoding the gene construct were 
mixed with ElectroLigase mix (New England Biolabs) in a final volume of 20 µl in 1x T4 DNA 
Ligase Reaction Buffer for 1 h. Ligated products were transformed into 50 µl of 
electrocompetent cells using an Electroporator 2510 (Eppendorf, Hauppauge, NY, USA) with an 
1800V pulse. Cells were re-suspended in 500 µl of Super optimal broth with catabolite 
repression (SOC) medium (20 g tryptone, 0.5 g yeast extract, 0.5 g 10 mM NaCl, 2.5 mM KCl, 
10 mM MgCl2, and 10 mM MgSO4 in 1L of deionized water adjusted to a final pH 7.0) and 
incubated for 1 h at 37 ℃ before plating. 
Auxotrophic E. coli strains  
We used two cysteine-dependent auxotrophic strains in this study. ΔcysE K-12 E. coli, a 
knockout strain, was provided through the in-house E. coli Keio Knockout Collection, which is a 
compilation of E.coli K-12 single-gene knockout mutants strains for all nonessential genes14. 
Since two O-acetylserine sulfhydrylases (A and B) are present in E. coli K-12 and unlike the 
description in the previous reports20, 21 that the single knockout strain for both genes (cysK and 
cysM) formed colonies on minimal medium without cysteine, we further constructed a 
ΔcysKΔcysM double knockout strain. First, the kanamycin marker was removed from the ΔcysM 
knockout strain, and then the ΔcysM::Km allele was introduced to the resulting strain through P1 
transduction. Kanamycin resistant colonies were picked and the target strain, lacking both the 
cysK and cysM genes, was selected via PCR using primers specifically designed for cysK 
(JW2407_cysK-up; CCAGTATTGCGATTACCCC and JW2407_cysK-down; 
TCGATTCAGCTTTGGCTTTT) and cysM (JW2414_cysM-up; 
CGAGCGTTTATTCGTTGGTC and JW2414_cysM-down; TTATCCGGCCTACAAAATCG). 
The cysK cysM double knockout strain did not form a colony on M9-glucose minimal medium 
for over 7 days. CysK and cysM are homologous genes that are responsible for the final step in 
cysteine biosynthesis; thus, ΔcysKcysM K-12 E. coli can serve as a cysteine-dependent 
conditional knockout strain. 
Preparation of electrocompetent cells 
 A single colony each of E. coli ΔcysE and ΔcysKΔcysM mutants were selected from a 
fresh Luria Broth (LB) +Kanamycin (Kan) plate and inoculated in 10 mL of 2xYT medium (16 g 
casein digest, 10 g yeast extract and 5g NaCl per 1L of deionized water adjusted to final pH 7.0) 
and grown overnight at 37 ℃ as a starter culture. The overnight culture was inoculated into 1 L 
of 2xYT medium and incubated at 37 ℃, shaking vigorously until it reached an OD600 of 0.6. 
The culture was then put on ice and centrifuged at 4 ℃ at 2500 x g for 25 min. The cells were 
washed two times with 800 mL of 4 ℃ deionized water. The culture was then re-suspended in 80 
mL of 10 % glycerol at 4 ℃, and pelleted at 4000 rpm for 10 min at 4 ℃. The supernatant was 
removed, and 2 ml of 10 % glycerol at 4 ℃ was added to the cells. For storage, the cells were 
dispensed into 100 µl aliquots, snap frozen in liquid N2, and stored at -80 ℃ for future use.  
Functional Screen for Cysteine Biosynthetic Enzymatic Function 
The pUC19 vectors containing cysE-C or cysE-CM genes were transformed into 
electrocompetent ΔcysE cells, while vectors with cysM-opt, cysM-C, and cysM-CM genes were 
transformed into electrocompetent ΔcysKΔcysM cells. One microliter of DNA was added to 79 
µl of cells thawed on ice, and the mixture was allowed to incubate at 4 ℃ for 10 min. The cells 
were then electroporated at 1800 volts pulse using an Eppendorf Electroporator 2510 
(Hauppauge, NY, USA), followed by incubation in 0.5 mL SOC medium at 37 ℃ for 15 min. 
After incubation, 0.5 µl of 0.4 M isopropyl-β-D-thiogalactoside (IPTG) was added, and the 
culture was allowed to incubate for an additional 30 min. The cells were then pelleted at 7500 x 
g for 90 seconds, washed with 500 µl of M9-glucose minimal medium, pelleted once again, and 
re-suspended in M9-glucose with 0.4 mM IPTG. The transformed cells were then plated on M9-
glucose minimal medium supplemented with 0.4 mM IPTG, 50 µg/ml kanamycin, and 100 
µg/ml ampicillin (M9-glucose +IPTG +Kan +Amp).  
The plates were left to incubate at 30 ℃ for one week (168 h) or until colonies formed, 
whichever occurred first. Colonies that formed on minimal medium were isolated. Two controls 
were also conducted. A positive control consisted of electrocompetent ΔcysE cells transformed 
with cysE in pUC19 and the other with electrocompetent ΔcysKΔcysM cells transformed with 
codon optimized cysM in pUC19. The cells were allowed to incubate at 30 ℃, overnight. The 
second positive control group supplemented the lack of cysteine through growing the knockout 
cells with empty pUC19 vectors on a fully supplemented media, LB +Amp, and were allowed to 
incubate at 37 ℃ overnight. Additionally, negative controls consisting of electrocompetent ΔcysE 
and ΔcysKΔcysM cells transformed with empty pUC19 expression vectors, were plated on 
minimal M9-glucose +IPTG +Kan +Amp media and allowed to incubate at 30℃ for 168 h.  
Colonies were picked and grown overnight in liquid LB +Kan +Amp media. Plasmids 
from rescued colonies were then purified using the QIAGEN QIAprep Spin Miniprep Kit. These 
plasmids were sequenced by Elim Biopharmaceuticals, Inc. (Hayward, CA US) with the forward 
primer 5’-CACTCATTAGGCACCCCAGG-3’ and the reverse primer 5’-
GAGACGGTCACAGCTTGTCT-3’. To confirm that the plasmids were responsible for rescuing 
the knock-out strains, the isolated plasmids and were re-transformed into respective new 
electrocompetent knockout cells. The cells were plated on M9-glucose +IPTG +Kan +Amp 
plates and allowed to incubate at 30℃ for 168 h or until colonies formed, whichever occurred 
first. 
Growth curve analysis 
A total of eight transformants: three cysE variants (cysE, cysE-C and cysE-CM) and 
empty pUC19 plasmid were transformed into the ΔcysE strain, and three cysM variants (cysM-
opt, cysM-C and cysM-CM) and empty pUC19 plasmid were transformed into the ΔcysKΔcysM 
strain. Single colonies were isolated from each plate of transformants and grown to 0.4-0.6 
OD600 in LB +Amp +Kan at 37 ℃. The cells were pelleted and washed with 0.9 % saline 
solution three times. Half of the cells were resuspended in LB +Amp +Kan and the other half of 
the cells were resuspended in M9-glucose +Amp +Kan. Excluding the transformants with empty 
pUC19 vector (controls), triplicate 200 µl cultures of each transformant in liquid LB +Amp 
+Kan +IPTG and M9-glucose +Amp +Kan +IPTG at 0.05 OD600 were added into a 96-well plate 
respectively. Two 200 µl cultures of ΔcysE and ΔcysKΔcysM with empty pUC19 vectors and 
blanks of LB +Amp +Kan +IPTG and two 200 µl blanks of M9-glucose +Amp +Kan+ IPTG 
were also added to the 96-well plate. To minimize condensation, the lid of the 96-well plate was 
coated with Triton X-100 by adding 3-4 mL of 0.05% Triton X-100 in 20% ethanol to the lid and 
ensuring even coverage of the lid22. The solution was then poured off after 30 s, and the lid was 
allowed to air-dry against a vertical surface. The plate was covered and then placed into a 
SPECTRAmax Plus384 microplate reader (Molecular Devices, Sunnyvale, CA) and the OD600 
was taken for 48 hours with an interval of three minutes. 
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 Figure 1. Two step cysteine biosynthesis pathway. The first step of cysteine synthesis is 
catalyzed by serine acetyltransferase, produced by the gene cysE. Serine acetyltransferase 
converts serine into O-acetylserine. From this step, O-acetylserine (thiol) sulfhydrylase, 
produced by gene cysK, converts the intermediate into cysteine. O-acetylserine sulfhydrylase 
function can also be provided by the homologous cysM gene. Thus, cysteine production in 
bacteria requires either cysE and cysK or cysE and cysM. In addition, genes similar to cysE, cysK, 
and cysM can be found within certain archaeal genomes (Kitabatake and So 2000). 
  
  
 
Figure 2. Cysteine and methionine residue substitution sites for cysE and cysM genes. A) 
Total of three cysteine residues (3, 23 and 83) and eight methionine residues (27, 48, 68, 77, 155, 
201, 204 and 206) were replaced to serine and leucine, respectively. B) Total of two cysteine 
residues (252, and 280), 11 methionine residues (27, 48, 68, 77, 155, 201, 204 and 206) were 
replaced to serine and leucine/isoleucine, respectively. ‘C to S’ represents cysteine to serine 
substitutions (blue), ‘M to L’ represents methionine to leucine substitutions (red), ‘M to I’ 
represents methionine to isoleucine substitutions (orange), and ‘active center’ represents amino 
acids involved in substrate recognition and catalytic activity of the enzyme (black). 
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Figure 3. Key residues highlighted on the crystal structure model of CysE and CysM 
proteins. Cartoon diagram of the trimer A) E.coli acetyltransferase protein (CysE, PDB ID: 
1T3D) and dimer B) E.coli cysteine synthetase B protein (CysM, PDB ID: 2BHS) are shown in 
gray scheme with each monomers in different exposure. The active site residues (red), 
substituted cysteine (yellow) and methionine (blue or purple) are highlighted in the left diagram. 
Methionines displayed in purple participate as an active site residue while methionines in blue 
are not part of the active site. Panels on the right represent the active center (top), the two closest 
cysteines (middle), and an example of methionine-aromatic motifs (bottom) found within the 
protein structures of CysE and CysM. Distances between each amino acid residue are denoted in 
angstroms. 
 
  
 Figure 4. Cysteine-dependent growth of ΔcysE and ΔcysKΔcysM E.coli knockout strains. 
Kanamycin resistant K-12 E. coli knockout strains ΔcysE and ΔcysKΔcysM were plated on LB 
medium supplemented with 50 µg/ml kanamycin, M9-glucose medium supplemented with 
0.5mM L-cysteine and 50 µg/ml kanamycin, and M9-glucose medium with 50 µg/ml kanamycin. 
For both strains, colonies were observed after incubation at 37℃ for 24 h on LB +Kan and 
incubation at 30℃ for 72 h on M9-glucose medium supplemented with L-cysteine (+cys) and 
kanamycin. Whereas, no growth was observed on M9-glucose medium supplemented with 
kanamycin. 
 
 
 
  
 Figure 5. Synthetic cysE and cysM gene transformants display recovery of CysE function 
without cysteine and methionine and CysM function without cysteine. A) E. coli ΔcysE 
competent cells were transformed with positive control cysE, two cysE variants cysE-C/cysE-CM 
cloned into the multiple cloning site of pUC19 plasmid, and original pUC19 encoding N-
terminal fragment of lacZα as a negative control. B) E. coli ΔcysMΔcysK competent cells 
transformed with positive control cysM-opt, two cysM variants cysM-C/cysM-CM in pUC19 
plasmid, and original pUC19 encoding N-terminal fragment of lacZα as a negative control. Cells 
were plated on M9-glucose medium with 0.4 mM IPTG, 50 µg/ml kanamycin, and 100 µg/ml 
ampicillin and incubated at 30 ℃ for 72 h. 
 
 
 
 
 
 
 
  
Figure 6. Growth curve of retransformed auxotrophic E.coli strains in LB and M9-glucose 
media. Each panel represents growth of cysteine-dependent E. coli auxotroph rescued by wild 
type enzymes: CysE and CysM (blue), cysteine-free enzymes: CysE-C and CysM-C (orange), 
sulfur-free enzymes: CysE-CM and CysM (yellow), and LacZα protein expressed from pUC19 
plasmid (gray). Growth curve was monitored at absorbance 600 nm using 96-well plate. 
Standard deviations of the growth curves are displayed and are calculated from triplicates. 
 
